Akebia Therapeutics | AKBA - Należności Handlowe





Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Ardelyx USD 82.84M 10.99M 2026-03
Astellas Pharma JPY 844.8B 83.04B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bayer EUR 18.7B 146M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Exelixis USD 322.21M 6.73M 2026-06
Fresenius Medical Care EUR 3.47B 250.22M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 22.54B 1.21B 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 53K 14K 2025-12
Pharma Mar EUR 58.06M 6.87M 2026-06
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 219.92M 38.3M 2026-03
Qiagen NV USD 398.35M 1.73M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Sartorius EUR 381.2M 14.6M 2026-06
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Zealand Pharma A/S 259M 81M 2026-03
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03